Etiology of hepatocellular carcinoma in Latin America: a prospective, multicenter, international study

被引:43
作者
Fassio, Eduardo [1 ]
Diaz, Solangel [2 ]
Santa, Catalina [3 ]
Elisa Reig, Maria [4 ]
Martinez Artola, Yamila [5 ]
de Mattos, Angelo Alves [6 ]
Miguez, Carlos [7 ]
Galizzi, Joao [8 ]
Zapata, Rodrigo [9 ]
Ridruejo, Ezequiel [10 ]
de Souza, Francisco Carlos [11 ]
Hernandez, Nelia [12 ]
Pinchuk, Leonardo [13 ]
机构
[1] Hosp Nacl Prof A Posadas, Buenos Aires, DF, Argentina
[2] Policlin Metropolitana, Caracas, Venezuela
[3] UIniv Antioquia, Hosp P Tobon Uribe, Medellin, Colombia
[4] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[5] Hosp Dr J Mendez, Buenos Aires, DF, Argentina
[6] Santa Casa Misericordia, Porto Alegre, RS, Brazil
[7] Hosp Dr B Udaondo, Buenos Aires, DF, Argentina
[8] Hosp Felicio Rocho, Belo Horizonte, MG, Brazil
[9] Clin Alemana, Santiago, Chile
[10] Ctr Educ Med & Invest Clin Norberto Quirno, Buenos Aires, DF, Argentina
[11] Hosp Mater Dei, Belo Horizonte, MG, Brazil
[12] Hosp Clin Montevideo, Montevideo, Uruguay
[13] Hosp Clin J de S Martin, Buenos Aires, DF, Argentina
关键词
Hepatitis C; Alcoholic cirrhosis; Cryptogenic cirrhosis; Hepatitis B; BCLC staging system; HEPATITIS-C VIRUS; CHRONIC LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; RISK-FACTORS; CRYPTOGENIC CIRRHOSIS; NATURAL-HISTORY; UNITED-STATES; ALCOHOL; MANAGEMENT; ANTIBODIES;
D O I
10.1016/S1665-2681(19)31681-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background/aims. No prospective study has been published investigating etiology of HCC in Latin America. The primary aim of this prospective study was to analyze the etiology of liver disease in patients with HCC from our area. Secondary aims were to evaluate staging using Okuda and BCLC classifications; and percentage of patients receiving treatment. Methods. The Governing Board of the Latin American Association for the Study of the Liver designed the protocol. During a 18 month period, all members were invited to load their incident HCC cases on line. Results. 240 cases from 9 countries were uploaded, 174 were male (72.5%), median age was 64 years, interquartile range 57-72. In 85.4% of cases, patients had underlying cirrhosis. Main etiological factors were: HCV in 74 patients (30.8%), alcohol in 49 (20.4%), cryptogenic cirrhosis in 35(14.6%), HBV in 26 (10.8%), HCV plus alcohol in 14 (5.8%). Considering the combinations, hepatitis C was shown in 91 patients (38%); chronic alcoholism in 68 patients (28%); and hepatitis B in 33 patients (14%). There were no significant differences between the groups in the age at diagnosis. Percentage of male gender was higher in groups of alcohol (94%), HCV plus alcohol (93%) and HBV (85%) than in cryptogenic cirrhosis (60%) and HCV (59%) (p<0.001). Conclusions. Our prospective study showed that hepatitis C is the more frequent etiology of HCC in Latin America, followed by alcoholic cirrhosis. Demographical results showed a male predominance (male:female ratio 2.6) with an important proportion of patients being diagnosed at their sixties.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 44 条
[1]
Aizawa Y, 2000, CANCER, V89, P53, DOI 10.1002/1097-0142(20000701)89:1<53::AID-CNCR8>3.3.CO
[2]
2-Y
[3]
International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis [J].
Alvarez, E ;
Berg, PA ;
Bianchi, FB ;
Bianchi, L ;
Burroughs, AK ;
Cancado, EL ;
Chapman, RW ;
Cooksley, WGE ;
Czaja, AJ ;
Desmet, VJ ;
Donaldson, RT ;
Eddleston, ALWF ;
Fainboim, L ;
Heathcote, J ;
Homberg, JC ;
Hoofnagle, JH ;
Kakumu, S ;
Krawitt, EL ;
Mackay, IR ;
MacSween, RNM ;
Maddrey, WC ;
Manns, MP ;
McFarlane, IG ;
zum Büschenfelde, KHM ;
Mieli-Vergani, G ;
Nakanuma, Y ;
Nishioka, M ;
Penner, E ;
Porta, G ;
Portmann, BC ;
Reed, WD ;
Rodes, J ;
Schalm, SW ;
Scheuer, PJ ;
Schrumpf, E ;
Seki, T ;
Toda, G ;
Tsuji, T ;
Tygstrup, N ;
Vergani, D ;
Zeniya, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (05) :929-938
[4]
Primary liver cancer:: Worldwide incidence and trends [J].
Bosch, FX ;
Ribes, J ;
Díaz, M ;
Cléries, R .
GASTROENTEROLOGY, 2004, 127 (05) :S5-S16
[5]
BRUIX J, 1989, LANCET, V2, P1004
[6]
Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[7]
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[8]
Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma [J].
Bugianesi, E ;
Leone, N ;
Vanni, E ;
Marchesini, G ;
Brunello, F ;
Carucci, P ;
Musso, A ;
De Paolis, P ;
Capussotti, L ;
Salizzoni, M ;
Rizzetto, M .
GASTROENTEROLOGY, 2002, 123 (01) :134-140
[9]
Obesity and hepatocellular carcinoma [J].
Caldwell, SH ;
Crespo, DM ;
Kang, HS ;
Al-Osaimi, AMS .
GASTROENTEROLOGY, 2004, 127 (05) :S97-S103
[10]
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638